Tuesday 16 July 2019

High Throughput Screening Market Size, Analysis, and Forecast Report 2019-2027

High Throughput Screening Market – Overview
High Throughput Screening (HTS) is an automated drug-discovery process that is typically utilized in the pharmaceutical business. It uses mechanization to identify active compounds, genes, or antibodies in a relatively short time frame.
The technique has its use in the initial stages of drug discovery pathway and in toxicology studies. Since HTS enables assaying of a large set of potential biological modulators against a chosen number of defined targets, it has attained the status of being a popular approach to the target validation.
The past few years have seen the HTS market growing in a pervasive manner owing to the proliferating pharmaceutical industry and the rising adoption of HTS in drug discovery. Moreover, the rising per capita healthcare expenditures coupled with the enhanced economic conditions are accelerating the market growth of HTS.

GET FREE SAMPLE COPY OF “Global High Throughput Screening Market Research Report- Forecast To 2027” @ https://www.marketresearchfuture.com/sample_request/1280

Market Research Future’s (MRFR) extensive and in-depth study of the global High-Throughput Screening market reveals that it will grow at an impressive rate during the assessment period of 2017-2027. Mounting investments in the healthcare sector and the shifting inclination towards high throughput research is pushing the growth of the market.
The HTS market, globally, is largely driven by efficacy & safety screening, target identification & validation, and monitoring of cell-based activity. Some of the additional pointers that would support the growth of the market are the rising drug discovery initiatives by academic and government institutions, huge acceptance of open innovation models by pharmaceutical organizations.

Global High Throughput Screening Market – Segments
The MRFR analysis is segmented into four key dynamics for the convenience of understanding;
By Product Type               :  Software, Instruments, and Consumables among others. 
By Application  :  Target Identification, Primary Screening, Toxicology, and Stem Cell Biology, among others.
By End-user                        :  Hospitals, Clinics, Pharmaceutical Companies/ Manufacturers, Government Organizations, and Research Facilities among others.
By Region                           :  North America, Europe, Asia Pacific (APAC), and the Rest-of-the-World (RoW).
The subsegment Instruments by product types is expected to witness significant growth in demand due to its increasing use in drug discovery processes, superior performance, and reduced system cost.
Owing to the extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications, the subsegment pharmaceutical, and biotechnology companies acquired the largest share in the global HTS market, by end users.

Leading Key Players
  • Roche (Switzerland)
  • Agilent Technologies Inc. (US)
  • Beckman Coulter, Inc. (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Life Technologies Corporation (US)
  • Aurora Biomed Inc. (Canada)
  • Bio-Rad Laboratories (US)
  • Luminex Corporation (US)
  • Sigma-Aldrich Corporation. (US) 
Detailed Regional Analysis
Globally, the North America region is the largest market for high throughput screening. Owing to the demanding research and development initiatives, the market is expected to grow at a significant rate of CAGR throughout the forecast period, creating a large revenue pocket by 2027. Factors substantiating the market growth include high healthcare expenditures and substantial investments in the R&D activities for medicine discovery.
Europe accounts for the second-largest market for high throughput screening which is expected to grow at a considerable CAGR during the forecast period. Favorable government support and initiatives drive the growth in the market extensively. The rapidly growing pharmaceutical sector in the region, backed by the resurging economy is fostering the market growth brilliantly.
Whereas, the Asia Pacific HTS market is growing rapidly, emerging as one of the lucrative markets, globally. Countries in the Asian region especially provide immense growth opportunities for the high-throughput screening market, accounting over half of the world’s total population. Furthermore, private equity firms and venture capitalists are increasingly investing in the HTS market in countries such as India, China, and Japan.


Competitive Analysis
Feb 12, 2019, NanoTemper Technologies announced the introduction of Dianthus, a technology that boasts the capability of fast, non-stop drug discovery screening. It can be integrated into any automation solutions and workflow with absolute ease. It has no down-time and can run for 24x7 without any requirement of cleaning. The technology stands out as the new benchmark in the high-throughput screening market.
Feb 04, 2019, Ncardia, a leading organization that offers human iPSC-derived cell-based services and assays for the discovery of drug and its development, revealed the launch of its new drug screening platform called DiscoverHIT. The platform enables researchers to bring better and accurate medicines to the patients in a faster and timely manner.

Hottest Trending Reports


 About Us: 
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us: 
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:
Labels: , ,

Monday 15 July 2019

Cancer Registry Software Market to Witness Surge in Demand Owing to Rising End-use Adoption


Market Highlights
The global Cancer Registry Software Market held a market value of USD 56.4 million in 2019 and is projected to grow at a CAGR of 10.7% over the forecast period.  
Cancer registry software is a disease registry that is mainly used to establish and maintain a cancer incidence reporting system. It acts as an informational resource for the investigation of cancer and its causes. This type of registry software is important as cancer is among the leading causes of death worldwide and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial to help identify trends and ultimately improve care for patients that are fighting cancer.
However, privacy and data security-related concerns and reluctance to adopt advanced solutions may restrict the growth of the market during the forecast period.
Key Players
Some of the prominent players in the global cancer registry software market are Onco, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Elekta AB (PUB), C/Net Solutions, Electronic Registry Systems, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Ordinal Data Inc, Conduent Inc, IBM, Himagine Solutions Inc.
Regional Analysis
On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the innovative product development and increasing investment in research and development for innovation in the region.  
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.
Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.
The Middle East & Africa has the least share of the global cancer registry software market.  Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Intended Audience
  • Software companies
  • Contract research organizations
  • Academic and research institutes
  • Government associations
Segmentation
The global cancer registry software market has been segmented into type, deployment model, database type, functionality and end user.
By type, the market has been segmented into integrated software and standalone software.
Based on deployment model, the market has been segmented into cloud-based models and on-premise models.
On the basis of database type, the market has been segmented into commercial databases and public databases.
By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.
The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.


Hottest Trends On Related Reports: 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Sunday 14 July 2019

Active Pharmaceutical Ingredients Market Manufacturing Market to Set Astonishing Growth from 2018– 2023

Active Pharmaceutical Ingredients Market Expected to Witness a Steady Rise
The drugs that we use, such as tablets, injectables, syrups, and capsules) are an amalgamated combination Active Pharmaceutical Ingredients (API) and excipients. It is a chemical or a drug which is responsible for the therapeutic and pharmacological activities in the human body. It is the most important ingredient in a drug that helps treat a disorder or a disease when administered. It is a substance that is integrated into a Finished Pharmaceutical Product (FPP). As per Market Research Future’s in-depth analysis of the global Active Pharmaceutical Ingredient (API) market, the growth trajectory of the market is projected to remain positive with a CAGR of 4.93% over the next five years of the forecast period.
APIs have gone on to become an integral component in the healthcare industry, primarily because of the clinical efficacy and value it offers. The development of advanced delivery systems coupled with the emergence of novel therapeutics is expected to expand the market opportunities of APIs in the forecast period. There also lies the growing trend concerning personalized medicines which can also influence the market landscape of APIs. The other factors driving the growth of the active pharmaceutical market are increased focus towards curbing down the pricing of manufacturing and supply chain consolidation.
Market Segmentation
The segmentation of the global Active Pharmaceutical ingredient market is based in terms of manufacturing process, application, API Formulation, type of synthesis, and molecules.
Manufacturing Basis: The market comprises of captive and contract manufacturing. The captive manufacturing segment holds the largest market share and is expected to maintain its hold in the forthcoming years.
Application Basis: The market includes neurological disorders, gastrointestinal disorders, orthopedic disorders, oncology, respiratory, urology, cardiovascular disease, and others. The oncology segment is projected to experience the fastest growth among all.
API Formulation Basis: The market covered are generic API and Innovative API. The generic API segment is the leading market player.
Type of Synthesis: The market is divided into synthetic and biotech.
Molecules Basis: The market is segmented into large molecules and small molecules.
Regional Outlook
The key markets for active pharmaceutical ingredients include South America, Europe, Asia Pacific, North America, and the Middle East & Africa.
North America is spearheading the API market growth in the Americas, which in turn is leading the global market with the largest share. The crucial factors backing the said growth include the presence of a large number of prominent companies within the region. In addition, countries like the United States (U.S.) and Canada note high occurrences of chronic as well as neurological diseases, which is believed to be a prominent driver of the regional market growth.
Europe has bagged the second spot in the global API market, backed by the increasing number of initiatives within the region that support the development of generic drugs. Moreover, improving pricing, as well as reimbursement policies coupled with a huge number of manufacturing activities, is presenting multiple growth opportunities to the regional market.
As the active pharmaceutical ingredients market has reached the maturity phase in the developed countries around the globe, the market focus is shifting towards the Asia Pacific. This factor has substantiated the region as the fastest-growing market globally. The presence of a humungous patient population within countries like India and China paired with the rising incidences of chronic diseases in the region is poised to benefit the market in the subsequent years. On top of that, availability of cheap labor and need for low investments in infrastructure are encouraging several renowned pharmaceutical vendors to outsource manufacturing to Asia Pacific, opening the door for further market success.
Competitive Analysis
The key companies identified in the global Active Pharmaceutical Ingredients Market are Merck & Co., Inc., GlaxoSmithKline Plc (GSK), F. Hoffmann-La Roche AG, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Boehringer Ingelheim GmbH, Pfizer Inc., Teva Pharmaceutical Industries Ltd. Bayer AG, and Sanofi.
On Feb 2019, ProvideGx, LLC, a subsidiary company of Premier Inc. which provides healthcare improvement services, announced its collaboration with Baxter Healthcare Corporation. The move is aimed to make additional generic drugs available to counter the rising drug shortage issue in the US.
On Feb 2019, TPG Growth, a private equity firm, revealed its plans of investing $30 million in Solara Active Pharma. The funding will help support the Chennai-based drug manufacturer, Solara Active Pharma, spread its wings of expansion in the regulated markets.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Wednesday 10 July 2019

Wearable Medical Device Market Expected to Witness a CAGR of 46.6% over 2022

Market Scenario
Market Research Future (MRFR) proclaims that the global wearable sensors market is estimated to register a striking CAGR of 46.6% during the forecast period (2018-2023). The continuously evolving sensor technology is favoring the market growth. The wearable sensor is referred to as a technological device which is worn by the individuals to track information associated with fitness and health. Such sensors are integrated into several accessories like hats, wristwatches, smartphones, eyeglasses, garments, shoes, wrist bands, headphones, and others which monitors and diagnose vital signs like blood pressure, heart rate, and other metabolic activities. These sensors enable biological and physiological sensing.


Market Potential and Pitfalls
The wearable sensors market is rapidly stealing the spotlight with increased consciousness regarding health and personal care. The demand for wearable fitness tracker is continuously on the rise to track biometrics like heart rate, calories burnt, and others. Internet of Things has mushroomed in the recent past which is triggering the demand for wearable sensors devices in application areas like consumer electronics, fitness and healthcare, and others. Wearable sensors enable continuous monitoring which has encouraged the behavior pattern of the buyers. There is a noticeable shift towards healthy lifestyle which has influenced people to adopt wearable sensors.
With the advancement in sensor technology, power supply technology, wireless communication devices/technology, and others, the wearable sensors market is receiving the pat. Boltt launched an AI-enabled wearable device in 2017 which constituted of smart shoes to sensors for health and fitness solutions. Factors such as advancements in sensor technology, surging adoption of remote and home patient monitoring, and increased use of wearable devices for infants have enabled the market to reach out to a wider range of audiences. The use of smart consumer electronic devices like smartphones and tablets have enabled the gathering and monitoring of data as these wearable sensors can be paired with other devices. The advent of new devices like the smart ring, smart shirt, eyewear, and others have further amplified the demand for wearable devices worldwide. With pressure sensors extremely becoming popular due to its miniaturization factor, the market is gaining impetus. Sensing muscle activity enables a sportsperson to train specific muscles and gain feedback regarding their performance quality. With pressure sensing shoes being used in motion capture technologies, the era of computer animation has transformed during the past decade.
On the contrary, the concerns associated with privacy, the high cost of the wearable sensors, and data integrity are some of the top barriers considered to vitiate the market growth in the coming years. On a brighter note, strict mandates related to data storage is likely to augment the popularity of wearable devices in the long run.
Global Wearable Sensors Market: Segmental Analysis
The global wearable sensors market has been segmented on the basis of type, application, and end-users.
By mode of type, the global wearable sensors market has been segmented into medical based sensors, motion sensors, position sensors, image sensors, inertial sensors, pressure sensors, and others.
By mode of application, the global wearable sensors market has been segmented into smart glasses, smart wristwear, smart footwear, smart body wears, and others. Among these, the smart wristwear segment occupied the major share across the globe. The growth is ascribed to the increased popularity of fitness and health devices among the consumers. New entrants are offering advanced technologies in smart wristwear at lower prices than smartwatches, which is likely to encourage the growth of the segment. These wristwear offer dynamic analysis of the user activities like heart rate variation, step tracking, sleep quality analysis, and calories count which further add to its functionality.
By mode of end-users, the global wearable sensors market has been segmented into healthcare, consumer, industrial and enterprise, and others. Among these, the consumer segment is likely to gain prominence. The demand for sensor-fused devices are triggering with the increased awareness regarding remote monitoring of fitness and wellness is gaining prominence among the users.
Regional Insights
Geographically, the wearable sensors market span across regions namely, Europe, North America, Asia Pacific, and the Rest-of-the-World (RoW).
Considering the global scenario, the North American region is poised to occupy the most significant share as the region offer room to the most prominent players and is in a position to adopt technological advancements at its earliest. High adoption of digital technology in the U.S. has further intensified the growth of the market in this region. With the booming healthcare infrastructure, the market is estimated to flourish.
The European region occupies the second spot and is anticipated to evolve at a significant pace in the foreseeable future. With advancing technology and purchasing power required for the market growth, the region is anticipated to gain an impetus. Moreover, the conscious awakening regarding healthy lifestyle is considered a major factor propelling the market growth in the long run.
The Asia Pacific region is estimated to expand at the fastest rate as the strong economic growth has infused healthy purchasing power which is estimated to encourage the proliferation of wearable sensors in the coming years.
Industry Updates
April 02, 2019: A team of researchers at the Binghamton University, State University of New York have recently developed skin-inspired electronics to conform to the skin, which allows high-performance, long-term, and real-time wound monitoring in the users.
Competitive Dashboard
The prominent players operating in the global wearable sensors market comprises Freescale Semiconductor Inc., KIONIX INC. (ROHM Co., Ltd.), InvenSense Inc., Panasonic Corporation, Analog Devices Inc., STMicroelectronics, ZOLL Medical Corporation (Asahi Kasei Corporation), InvenSense Inc., Measurement Specialties Inc., Robert Bosch GmbH, Infineon Technologies AG., and Texas Instruments Incorporated.
Table Of Content
1. Report Prologue
2. Market Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
6. Global Wearable Sensors Market, By Deployment
7. Global Wearable Sensors Market, By Application
8. Global Wearable Sensors Market, By End User
……
List Of Tables:
TABLE 1 Specific Primary And Secondary Sources Used For This Publication 14 
TABLE 2 Global Wearable Sensors Market Snapshot(2015and 2020) 16 
TABLE 3 Drivers For The Market: Impact Analysis 29 
TABLE 4 Restraints For The Market: Impact Analysis 32 
TABLE 5 Global Market Breakdown By Type, $M (2012 – 2014) 36 
TABLE 6 Global Market Breakdown By Type, Million Units (2012 – 2014) 37 
TABLE 7 Global Market Breakdown By Type, $M (2015 – 2020) 37 
TABLE 8 Global Market Breakdown By Type, Million Units (2015 – 2020) 38 
TABLE 9 Global Market Breakdown By Application, $M (2012 – 2014) 39 
TABLE 10 Global Market Breakdown By Application, Million Units (2012 – 2014) 40 
TABLE 11 Global Market Breakdown By Application, $M (2015 – 2020) 40 
TABLE 12 Global Market Breakdown By Application, Million Units (2015 – 2020) 40 
TABLE 13 Global Market Breakdown By End User, $M (2012 – 2014) 41 

Read More @ https://www.marketresearchfuture.com/reports/wearable-sensors-market-955

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , , ,

Tuesday 9 July 2019

Cancer Biological Therapy Market: Analysis Regions (North America, Europe, Middle East, ROA, Africa) 2018-2023

Cancer Biological Therapy Market Highlights
Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors.
Get Latest Sample PDF Of Cancer Biological Therapy Market Report @ https://www.marketresearchfuture.com/sample_request/566
Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Most of the biological therapies use bacteria or vaccines to mimic the body’s immune system to act against cancer developing cells. These various types of biological therapies, which are most of the times stated to biological response modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.
Cancer Biological Therapy Market Segmentation:
The global Cancer Biological Therapy market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors. Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.
Cancer Biological Therapy Market Regional Analysis:
Global cancer biological therapy market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa. North America is expected to commands the largest market share due to advanced technologies are continuously on rise in these countries. Europe accounts for the second largest market, where as Asia Pacific with lots of opportunity and continuously growing economies, is expected to be the fastest growing segment. Majorly due to recent developments in healthcare and improving economies. Middle East and Africa with less economic developments and extremely low income accounts for least market share in 2016 but is expected to grow with better cancer treatment in the countries.
Global Cancer Biological Therapy Market Players:
Key players profiled in the report are Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, ELI Lilly and Company, F. Hoffmann-La Roche AG, EnGeneIC Ltd, Merck & Co., Inc., Novartis,Pfizer Inc. and others.
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Pricing Analysis
Chapter 6. Global Cancer Biological Therapy Market, By Type
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email:  sales@marketresearchfuture.com

Posted by at No comments:
Labels: , ,

Sunday 7 July 2019

Rheumatoid Arthritis Market Robust Expansion by Top Key Manufactures | Worldwide Overview by Upcoming Trends, Size, Share, Segments, Top 10 Players Analysis By 2022

During old age, rheumatoid arthritis problem is common. And smokers are more prone to it. Contrary to popular belief, rheumatoid arthritis goes beyond joint pain. Sometimes, it can also damage various parts of the body system that include blood vessels, eyes, heart, lungs, and skin. Therefore, the rheumatoid arthritis market is growing.
FREE SAMPLE COPY OF Rheumatoid Arthritis Market Research Report- Global forecast till 2023” @https://www.marketresearchfuture.com/sample_request/1658
Market Research Future (MRFR) has published a research report that predicts success for the global rheumatoid arthritis market with 4% CAGR (Compound Annual Growth Rate) between 2017 and 2022. Analyzing the market structure, this report evaluates the future growth potential and observes the strategies of the key players in this market. It also tracks the competitive developments such as joint ventures, mergers, and acquisitions, new product developments, new product developments (R & D) in the market. According to a study, the women are three times more prone to this disease than men. The key factors that can impact the market growth include a high number of individuals suffering from the autoimmune disease.
The global rheumatoid arthritis market has been segmented on the basis of diagnosis, drug type, treatment, and lastly, region. Based on the diagnosis, the market has been segmented into the C-Reactive Protein (CRP) Test, cyclic citrullinated peptide (CCP), and erythrocyte sedimentation rate (ESR) test.  By drug types, the market has been segmented into biologic agents, Disease-modifying anti-rheumatic drug type (DMARDs), Non-steroidal anti-inflammatory drug type (NSAID), and steroids. The treatment-based market segmentation covers joint fusion, synovectomy, and tendon repair. Joint fusion welds the bones to relieve joint pain. Via synovectomy, the synovial tissue surrounding a joint is removed. Tendon repair is surgery required for treating a torn or damaged tendon.
The regional segmentation of the global Rheumatoid Arthritis Market segments the market into regional markets namely Europe, North America, Asia Pacific, and the Middle East & Africa. North America is the biggest market due to advanced medical facilities being available here, and it is expected to grow during the forecast period. The cream of this market comprises of the United States of America (USA) and Canada. Europe, the second largest market for rheumatoid arthritis is also expected to grow during the forecast period. After Europe, North America has maximum advanced medical facilities. Maximum revenue of this market comes from France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Europe.
Asia Pacific market is expected to be the fastest growing market for rheumatoid arthritis during the forecast period due to medical facilities improving in this region with growing urbanization and steady technological advancement that is giving rise to medical tourism in Asia Pacific region. The biggest share in the Asia Pacific region is commanded by Australia, China, India, Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is the smallest regional market. Due to lack of education, less infrastructure development, limited growth in the healthcare sector, and political instability, the market is low in this region. Maximum revenue for this market is generated by Egypt, Saudi Arabia, South Africa, and United Arab Emirates (UAE), followed by rest of the MEA region.
Key Players
The key players in the global rheumatoid arthritis market include AstraZeneca (UK), Bristol-Myers Squibb Company (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Pfizer Inc (USA), Sanofi (France), and Vertex Pharmaceuticals Incorporated (USA).
Latest Industry News
  • Zydus Cadila has obtained approval from the United States Food and Drug Administration (USFDA) to market Piroxicam Capsules USP that are useful for the treatment of osteoarthritis and rheumatoid arthritis. 19 JUL 2018
  • Celltrion is working on the clinical trials of its versions of AbbVie’s rheumatoid arthritis treatment Humira and Roche’s oncology therapy Avastin. 16 JUL 2018
ntended Audience
  • Pharmaceutical companies
  • Rheumatoid arthritis treatment centers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities
Table Of Contnets
. INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3. MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
...
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Friday 5 July 2019

Opioids Market 2019 Trends, Industry Size, Segmentation, Sales Revenue, Growth Factors, Key Players Update, Demand Comprehensive Research Study Till 2023 - Market Research Future

Market Highlights
The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.
The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years. However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.
Segment analysis
The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

Regional Analysis
The Americas is expected to hold the largest share of the global opioids market. This is owing to rising intravenous usage of opioids in the region. Also, high awareness among people regarding the medical uses of opioids is expected to drive the market growth in the region.
Europe showed a considerable amount of growth in the market due to increasing palliative care facilities and reformed regulations for the prescription of opioids. Asia-Pacific is estimated to be the fastest growing region in the global market. Populace demographics and increased availability of effective opioid medications are likely to be the key factors for the growth of Asia-Pacific opioids market during the forecast period. South Korea held a share of 6% in the Asia-Pacific opioids market in 2017. Also, the Middle East and Africa region is expected to steadily grow owing to the rising number of opioid manufacturers in the North African region.
Key Findings of the Study
  • The global opioids market is projected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% during the review period from 2018 to 2023
  • Americas accounted for the largest share of the global market due to rising intravenous drug use in the region.
  • The extended-release opioid segment accounted for the largest product segment revenue of USD 12,750.91 million in 2017.
  • Some of the players operating in the opioids market are Egalet Corporation, Purdue Pharma L.P., and Vertice Pharma, among others.
This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global opioids market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.
Related Reports
  • Medical Morphine Market Information: By Route of Administration (Oral, Injectable) Application (Arthritis, Cancer, Kidney Stones,) Distribution Channel (Hospital Pharmacy, Online Pharmacy), and End-User (Hospitals & Clinics )– Global Forecast Till 2023
  • Global Medical Marijuana Market: Information by Application (Cancer, Multiple Sclerosis, Alzheimer’s, and Muscle Spasms), Route of Administration (Oral, Topical, and Others), Distribution Channel (Dispensaries and Others) – Global Forecast Till 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)